Abstract: Systems, methods, and computer-readable media for validating online access to secure device functionality are provided that may use shared secrets between different subsystems and limited use validation data.

Abstract: A system for delivering a voltage to at least one power domain has at least one component. Each power domain functions according to at least two operating points, each operating point requiring a distinct supply voltage. The system includes at least two power supply units, alternatively delivering controllable supply voltages. The system also includes a control unit that selects one of the power supply units to be connected to a power domain, based on a current operating point of the power domain. The control unit also controls the supply voltage delivered by the selected power supply unit, to deliver the required voltage level associated with the current operating point of the power domain.

Abstract: It is provided a pharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, at least one sterol or an ester thereof and a mixture of acylglycerols with a solid fat content of less than 25% at 25° C. and 0% at 37° C. In addition it is provided a method for preparing the pharmaceutical composition.

Abstract: A floor system (10) arranged on an inner floor (4) of a cargo or a back space (2) of a service vehicle (1), and comprising a first and a second prefabricated floor section (11?, 11?), each one of said first and said second floor sections (11?, 11?) comprises: a floor panel (13) comprising a first edge (13a) and a second edge (13b), wherein said first edge (13a) is arranged opposite said second edge (13b), said first and said second floor sections (11?, 11?) are arranged next to each other such that said second edge (13b) of said floor panel (13) of said first floor section (11?) is placed facing and adjacent to, or in contact with said first edge (13a) of said floor panel (13) of said second floor section (11?); a first securing rail (12?) fixedly attached to a third edge (13c) of said floor panel (13), said third edge (13c) extending at a right angle from said first edge (13a) to said second edge (13b) of said floor panel, and said floor system (10) further comprising: a floor portion (20, 20?), which is sma

Abstract: The present invention relates to method and arrangement in cellular mobile communication systems, in particular for handling of a physical random access channel for example in a Long Term Evolution communication network. By sending to at least one user equipment, UE, in a communication network cell an un-solicited speculative random access response, RAR, message comprising information relating to at least one of pre-amble identifier, allocated UE identifier, and uplink resource allocation data for L2/L3 message, it is possible to reduce the complexity of the access node, e.g. an eNodeB.

Abstract: A lipid layer forming composition comprises a volatile silicone oil of a boiling point above 180° C., a polar lipid, optionally a C2-C4 aliphatic alcohol, optionally a pharmacologically or cosmetically active agent or a protective agent. The lipid layer forming composition can be applied to a biological surface by spraying, dipping or brushing to form a stable polar lipid layer on the surface.

Abstract: The present invention provides methods for predicting response to a hormone-directed therapy or chemotherapy in a prostate cancer (PCa) patient comprising (a) performing a direct analysis comprising immunofluorescent staining and morphological characterization of nucleated cells in a blood sample obtained from the patient to identify and enumerate circulating tumor cells (CTC); (b) individually characterizing genotypic, morphometric and protein expression parameters to generate a profile for each of the CTCs, and (c) predicting response to hormone-directed therapy in the prostate cancer PCa patient based on said profile. In some embodiments, the methods comprise repeating steps (a) through (c) at one or more timepoints after initial diagnosis of prostate cancer to sequentially monitor said genotypic, morphometric and protein expression parameters.

Abstract: A measuring system for measuring the concentration of substances or analytes in a body fluid or in a body tissue comprises a microdialysis probe comprising a microdialysis membrane, the probe being adapted to be placed in blood or in tissue, a flow through sensor for analyzing a fluid having passed the microdialysis probe, a pump for pumping the fluid to and through the microdialysis probe and further to and through the sensor, and tubing connecting the pump to the microdialysis probe and the microdialysis probe to the sensor. The pump effects a flow rate in the system in the interval 0.2-15 microliters per minute. The sensor comprises a flow channel having a flow resistance or pressure drop adapted to the characteristics of the microdialysis membrane so as to eliminate, or at least substantially reduce, ultra filtering in the microdialysis membrane.

Abstract: There is provided homogeneous pharmaceutical compositions for the treatment of inflammatory disorders comprising an antiinflammatory and/or antihistaminic active ingredient, a polar lipid liposome and a pharmaceutically-acceptable aqueous carrier.

Abstract: The embodiments herein relate to a method in a network node (101) for handling states associated with a wireless device (105) in a communications network (100). The network node (101) is connected to the wireless device (105) over a communications link (110). The communications link (110) is in a current state. The network node (101) receives, from the wireless device (105) information related to a data activity in the wireless device (105). The received information comprises at least information other than a current amount of data associated with the data activity. Based on the received information, the network node (101) determines a change associated with the current state.

Abstract: Carboxymethylcellulose, notably sodium carboxymethylcellulose or other alkali metal or alkaline earth metal salts of carboxymethylcellulose, are employed to control solidification time of compositions comprising one or more bioresorbable ceramics, notably a hydratable calcium sulphate, in order to facilitate preparation of a ready-to-use composition for inserting into the body by injection.

Abstract: Use of the antimicrobial cathelicidin peptide II-37, N-terminal fragments of LL-37 or extended sequences of LL-37 having 1-3 amino acids in the C-terminal end, for stimulating proliferation of epithelial and stromal cells and thereby healing of wounds, such as chronic ulcers. The cytotoxic effect of LL-37 may be reduced by including a bilayer-forming polar lipid, especially a digalactosyldiacylglycerol, in pharmaceutical compositions and growth media comprising LL-37.

Abstract: A measuring system (100) for continuously measuring body fluid constituents, said measuring system (100) comprising a microdialysis catheter or probe (110) comprising a microdialysis membrane (116) to be placed in a blood stream or in tissue fluid. The measuring system further comprises a flow through sensor (200) for continuously measuring the concentration of substances present in the fluid that has passed the microdialysis membrane (116). The measuring system (100) further comprises a waste container (126).

Abstract: A method in a communication device and a communication device (100) for adapting a transmission of data are provided. The transmission is transferred from a first chip (110) to a second chip (120) over a chip-to-chip interface (104, 304). The chip-to-chip-interface comprises a wired connection between the first chip and the second chip which is comprised in the communication device. The communication device receives (201) the radio signal (330), comprising the transmission of data from another communication device. The communication device determines (202), from the received radio signal (330), modulation and coding information, which is used for determining (203) a channel quality. Further, the communication device (100) adapts (204) the transmission of data based on the determined channel quality of the received radio signal (330) in such way that at least the determined channel quality is obtained when transferring (205) the transmission of data over the chip-to-chip interface to the second chip.

Abstract: The invention discloses a shelf system in a service vehicle (1) comprising a base (11) for arranging articles thereon and a first side wall (13a), wherein said first side wall (13a) comprises a first wall portion (21) connected to the base (11) and a second wall portion (22), wherein said first wall portion (21) continues into said second wall portion (22) and said second wall portion (22) overlaps at least partly said first wall portion (21) in such a way that said first and second wall portions (21, 22) form a channel (23) along the longitudinal direction of the first side wall, and said second wall portion (22) is at least in some locations connected to said first wall portion (21) along the longitudinal direction of the first side wall (21) so that said channel (23) is at least partly a closed channel (23) in the longitudinal direction of the first side wall (21).

Abstract: The present invention provides methods for diagnosing lung cancer in a subject comprising (a) generating circulating tumor cell (CTC) data from a blood sample obtained from the subject based on a direct analysis comprising immunofluorescent staining and morphological characteristics of nucleated cells in the sample, wherein CTCs are identified in context of surrounding nucleated cells based on a combination of the immunofluorescent staining and morphological characteristics; (b) obtaining clinical data for the subject; (c) combining the CTC data with the clinical data to diagnose lung cancer in the subject.

Abstract: It is provided apharmaceutical composition comprising 3-beta-hydroxy-5-alpha-pregnan-20-one, at least one sterol or an ester thereof and a mixture of acylglycerols with a solid fat content of less than 25% at 25° C. and 0% at 37° C. In addition it is provided a method for preparing the pharmaceutical composition.

Abstract: A measuring system for measuring the concentration of substances or analytes in a body fluid or in a body tissue comprises a microdialysis probe comprising a microdialysis membrane, the probe being adapted to be placed in blood or in tissue, a flow through sensor for analysing a fluid having passed the microdialysis probe, a pump for pumping the fluid to and through the microdialysis probe and further to and through the sensor, and tubing connecting the pump to the microdialysis probe and the microdialysis probe to the sensor. The pump effects a flow rate in the system in the interval 0.2-15 microliters per minute. The sensor comprises a flow channel having a flow resistance or pressure drop adapted to the characteristics of the microdialysis membrane so as to eliminate, or at least substantially reduce, ultra filtering in the microdialysis membrane.

Abstract: The present invention relates to a novel pharmaceutical composition comprising oxytocin and/or one or more fragment(s) and/or variant(s) thereof and at least one non-ionic cellulose ether, such as hydroxypropylmethylcellulose, said pharmaceutical composition having a low pH. The present pharmaceutical composition has been shown to provide an exceptionally suitable environment for oxytocin, as the stability thereof has increased significantly as compared to previous compositions with this molecule. The pharmaceutical composition according to the invention can be used for medical purposes, such as in the treatment of climacteric disorders.

Abstract: The present invention relates to method and arrangement in cellular mobile communication systems, in particular for handling of a physical random access channel for example in a Long Term Evolution communication network. By sending to at least one user equipment, UE, in a communication network cell an un-solicited speculative random access response, RAR, message comprising information relating to at least one of pre-amble identifier, allocated UE identifier, and uplink resource allocation data for L2/L3 message, it is possible to reduce the complexity of the access node, e.g. an eNodeB.